C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
1.644
-0.106 (-6.07%)
Mar 31, 2025, 1:41 PM EDT - Market open

C4 Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
35.5820.7631.145.7933.2
Upgrade
Revenue Growth (YoY)
71.44%-33.25%-32.08%37.93%55.25%
Upgrade
Cost of Revenue
110.64117.71117.8494.6778.44
Upgrade
Gross Profit
-75.05-96.95-86.75-48.88-45.25
Upgrade
Selling, General & Admin
42.1242.0842.7933.2515.2
Upgrade
Operating Expenses
42.1242.0842.7933.2515.2
Upgrade
Operating Income
-117.18-139.03-129.53-82.13-60.45
Upgrade
Interest Expense
--1.37-2.22-2.15-1.23
Upgrade
Interest & Investment Income
9.036.034.292.270.3
Upgrade
Other Non Operating Income (Expenses)
-----5.68
Upgrade
EBT Excluding Unusual Items
-108.14-134.38-127.46-82.01-67.06
Upgrade
Merger & Restructuring Charges
-2.44----
Upgrade
Gain (Loss) on Sale of Investments
5.43.78-0.71-1.880.1
Upgrade
Other Unusual Items
--0.62---
Upgrade
Pretax Income
-105.19-131.21-128.18-83.89-66.96
Upgrade
Income Tax Expense
0.131.28---0.63
Upgrade
Net Income
-105.32-132.49-128.18-83.89-66.34
Upgrade
Net Income to Common
-105.32-132.49-128.18-83.89-66.34
Upgrade
Shares Outstanding (Basic)
6950494611
Upgrade
Shares Outstanding (Diluted)
6950494611
Upgrade
Shares Change (YoY)
39.75%1.59%6.13%304.93%728.80%
Upgrade
EPS (Basic)
-1.52-2.67-2.62-1.82-5.83
Upgrade
EPS (Diluted)
-1.52-2.67-2.62-1.82-5.83
Upgrade
Free Cash Flow
-65.34-108.55-111.44-88.24-67.9
Upgrade
Free Cash Flow Per Share
-0.94-2.19-2.28-1.92-5.97
Upgrade
Gross Margin
-210.92%--278.96%-106.76%-136.30%
Upgrade
Operating Margin
-329.30%-669.83%-416.56%-179.39%-182.10%
Upgrade
Profit Margin
-295.96%-638.34%-412.19%-183.23%-199.83%
Upgrade
Free Cash Flow Margin
-183.61%-522.96%-358.36%-192.73%-204.55%
Upgrade
EBITDA
-115.36-137.15-127.86-80.64-58.83
Upgrade
EBITDA Margin
----176.13%-177.23%
Upgrade
D&A For EBITDA
1.821.881.681.491.62
Upgrade
EBIT
-117.18-139.03-129.53-82.13-60.45
Upgrade
EBIT Margin
----179.39%-182.10%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q